1118
In this report, one patient who developed gangrene after bleomycin and vincristine/vinblastine chemotherapy for AIDS-related Kaposi's sarcoma and another HIV-infected patient who exhibited symptoms of severe Raynaud's phenomenon related to the same regimen are presented.
 one patient: Subject; one: Subject.Population; gangrene: Effect; bleomycin and vincristine/vinblastine: Treatment; bleomycin: Treatment.Drug; vincristine: Treatment.Drug; vinblastine: Treatment.Drug; bleomycin: Combination.Drug; vincristine: Combination.Drug; vinblastine: Combination.Drug
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 one patient: Subject; one: Subject.Population; gangrene: Effect; bleomycin and vincristine/vinblastine: Treatment; bleomycin: Treatment.Drug; vincristine: Treatment.Drug; vinblastine: Treatment.Drug; bleomycin: Combination.Drug; vincristine: Combination.Drug; vinblastine: Combination.Drug